iBio IBIO
NASDAQ IBIO
$1.18 +0.01 (+0.95%)
As of: Sep 30, 2026 · 9:55 AM EDT

iBio (IBIO) Acquisitions (2022)

Updated

iBio (IBIO) posted Acquisitions of $692,000 for FY2023 (year ended Jun 30, 2023).

Analysis

iBio (IBIO) Acquisitions (2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn -17.24 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -23.00 Mn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn -
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.21 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 iBio 121.75 Mn 121.75 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 692,000.00
API Access

iBio Acquisitions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=acquisitions&ticker=IBIO&period=max&api_key=YOUR_API_KEY